Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;135(3):485-488.
doi: 10.1007/s00401-018-1820-4. Epub 2018 Feb 10.

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway

Affiliations

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway

Melike Pekmezci et al. Acta Neuropathol. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no competing interests related to this study.

Figures

Figure 1.
Figure 1.
Multinodular and vacuolating neuronal tumor of the cerebrum (MVNT) is defined by genetic alterations that activate the MAP kinase signaling pathway. a, Table of the clinicopathologic features of the eight patients with MVNT and the pathogenic genetic alterations identified in this study. b-e, Pre-operative axial (b-c) and coronal (d-e) T2-weighted magnetic resonance imaging for patient MVNT #1. fg, H&E staining (f) and phospho-ERK immunostaining (g) on MVNT #7. h, Snapshot from the Integrated Genome Viewer for MVNT #7 showing sequencing reads containing a small in-frame deletion in exon 2 of the MAP2K1 gene.

References

    1. Alsufayan R, Alcaide-Leon P, de Tilly LN, Mandell DM, Krings T (2017) Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor. Neuroradiology 59:873–883. - PubMed
    1. Arai Y, Totoki Y, Hosoda F et al. (2014) Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 59:1427–1434. - PubMed
    1. Brown NA, Furtado LV, Betz BL et al. (2014) High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124:1655–1658. - PubMed
    1. Cathcart SJ, Klug JR, Helvey JT, L White M, Gard AP, McComb RD (2017) Multinodular and vacuolating neuronal tumor: a rare seizure-associated entity. Am J Surg Pathol 41:1005–1010. - PubMed
    1. Chakraborty R, Burke TM, Hampton OA et al. (2016) Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood 128:2533–2537. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources